Carvedilol Tablet, Film Coated
Product Images NDC 50090-4898

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-4898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This appears to be a chart or a figure with two columns showing the names of two treatments - Placebo and Carvedilol - and a p-value of 0.0014 for Carvedilol. There are also numbers (3, 6, 9, 12, 15, 18, 21) arranged in a row. Based on this text only it is difficult to determine what the chart represents or what study it is from.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
The text describes a figure showing survival analysis for a study referred to as CAPRICORN using two treatments: placebo and carvedilol. There are two groups of patients identified in the figure, one with 30 patients on placebo treatment and the other with 204 patients on the same treatment. The group treated with carvedilol had 104 patients. The figure shows the results of the survival analysis, with time (in months) on the x-axis and the percentage of patients surviving on the y-axis. There is also a P-value of 0.03 indicated, suggesting that there is a statistically significant difference in survival between the two treatments.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This is a table showing the effects on mortality of subgroups in CAPRICORN. The subgroups are divided by age, gender, use of diuretics, randomized day post MI, hypertension, diabetes, Killip class, heart rate, thrombolytic use, and PTCA for MI. Hazard ratios are also provided but no further information is available to understand the context of the study.*
FDA Label Image

Label Image (Lbl500904898)

Label Image (Lbl500904898)
This appears to be a product label for a bottle of tablets with the brand name "Prndu!" and the product code "No. 9513-0." The bottle contains 90 tablets and the label also includes a batch number, "251G," and a statement about the quantity of tablets, "S1one AT s 107 pecaces." However, it is not clear what the tablets are intended to treat or what their ingredients might be.*
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.